Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.95
-0.22 (-2.69%)
At close: May 12, 2026, 4:00 PM EDT
7.95
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $83.48 million as of May 12, 2026. Its market cap has increased by 56.38% in one year.
Market Cap
83.48M
Enterprise Value
-59.78M
1-Year Change
56.38%
Ranking
Category
Stock Price
$7.95
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $83.48M, a decrease of -72.33%. That is a compound annual growth rate of -20.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 85.79M | 0.82% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 96.41M |
| Rani Therapeutics Holdings | 96.37M |
| Rein Therapeutics | 95.21M |
| NeurAxis | 94.34M |
| LeonaBio | 94.31M |
| aTyr Pharma | 92.79M |
| Q32 Bio | 91.06M |
| ProMIS Neurosciences | 88.15M |